PharmTech Poll Results: Outsourced or In-house?
View the results of our poll on what services companies who outsource usually decide to keep in-house.
The question:
If your company uses contract service providers and manufacturers, which function(s) do you typically keep in-house?
Your responses:
- Discovery research (1 response)
- Preclinical animal research
- ADME-tox work
- Formulation development (1 response)
- Process development (1 response)
- Clincial-scale manufacturing through Phase I
- Clinical-scale manufacturing through Phase II
- Clinical-scale manufacturing through Phase III
- Clinical trials
- Scale-up to commercial manufacturing (2 responses)
- Commercial-scale manufacturing (2 responses)
- Fill-finish
- Other
Do you have any comments on this poll, or would you like to submit your vote? Email us at [email protected].
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
